Skip to main content

Advertisement

SpringerLink
Log in

Bone and Cytokines: Beyond IL-1, IL-6 and TNF-α

  • Editorial
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Luben RA, Mundy GR, Trummel CL, Raisz LG (1974) Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes. J Clin Invest 53:1473–1480

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Elmslie RE, Dow SW, Ogilvie GK (1991) Interleukins: biological properties and therapeutic potential. J Vet Intern Med 5:283–293

    Article  CAS  PubMed  Google Scholar 

  3. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC (1992) 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883–891

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Girasole G, Passeri G, Pedrazzoni M, Giuliani N, Passeri M (1995) Interleukin-6: a pathogenetic role in the postmenopausal osteoporosis? Acta Biomed Ateneo Parmense 66:125–138

    CAS  PubMed  Google Scholar 

  5. Rifas L, Kenney JS, Marcelli M, Pacifici R, Cheng SL, Dawson LL, Avioli LV (1995) Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids. Endocrinology 136:4056–4067

    CAS  PubMed  Google Scholar 

  6. Keeting PE, Rifas L, Harris SA, Colvard DS, Spelsberg TC, Peck WA, Riggs BL (1991) Evidence for interleukin-1 beta production by cultured normal human osteoblast-like cells. J Bone Miner Res 6:827–833

    Article  CAS  PubMed  Google Scholar 

  7. MacDonald BR, Gowen M (1992) Cytokines and bone. Br J Rheumatol 31:149–155

    Article  CAS  PubMed  Google Scholar 

  8. Girasole G, Passeri G, Jilka RL, Manolagas SC (1994) Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 93:1516–1524

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Littlewood AJ, Russell J, Harvey GR, Hughes DE, Russell RG, Gowen M (1991) The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology 129:1513–1520

    Article  CAS  PubMed  Google Scholar 

  10. Marie PJ, Hott M, Launay JM, Graulet AM, Gueris J (1993) In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation. J Clin Endocrinol Metab 77:824–830

    CAS  PubMed  Google Scholar 

  11. Thomson BM, Saklatvala J, Chambers TJ (1986) Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med 164:104–112

    Article  CAS  PubMed  Google Scholar 

  12. Thomson BM, Mundy GR, Chambers TJ (1987) Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775–779

    CAS  PubMed  Google Scholar 

  13. Gowen M, Wood DD, Ihrie EJ, McGuire MK, Russell RG (1983) An interleukin 1-like factor stimulates bone resorption in vitro. Nature 306:378–380

    Article  CAS  PubMed  Google Scholar 

  14. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297–3303

    CAS  PubMed  Google Scholar 

  15. Pacifici R, Rifas L, Teitelbaum S, Slatopolsky E, McCracken R, Bergfeld M, et al (1987) Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 84:4616–4620

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA (1989) Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398–2402

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Pacifici R, Rifas L, McCracken R, Avioli LV (1990) The role of interleukin-1 in postmenopausal bone loss. Exp Gerontol 25:309–316

    Article  CAS  PubMed  Google Scholar 

  18. Johnson RA, Boyce BF, Mundy GR, Roodman GD (1989) Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 124:1424–1427

    Article  CAS  PubMed  Google Scholar 

  19. Mundy GR (1991) Inflammatory mediators and the destruction of bone. J Periodontal Res 26:213–217

    Article  CAS  PubMed  Google Scholar 

  20. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319:516–518

    Article  CAS  PubMed  Google Scholar 

  21. Kimble RB, Matayoshi AB, Vannice JL, Kung V, Williams C, Pacifici R (1995) Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136:3054–3061

    CAS  PubMed  Google Scholar 

  22. Passeri G, Girasole G, Manolagas SC, Jilka RL (1994) Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: influence on IL-6 production and osteoclast development. Bone Miner 24:109–126

    Article  CAS  PubMed  Google Scholar 

  23. Cohen-Solal ME, Graulet AM, Denne MA, Gueris J, Baylink D, de Vernejoul MC (1993) Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 77:1648–1653

    CAS  PubMed  Google Scholar 

  24. Ralston SH, Russell RG, Gowen M (1990) Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 5:983–988

    Article  CAS  PubMed  Google Scholar 

  25. Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, Hilton DJ, Suda T, Ng KW, Martin TJ (1996) The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 183:2581–2591

    Article  CAS  PubMed  Google Scholar 

  26. Suda T, Nakamura I, Jimi E, Takahashi N (1997) Regulation of osteoclast function. J Bone Miner Res 12:869–879

    Article  CAS  PubMed  Google Scholar 

  27. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T (1993) Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc National Academy of Sciences USA 90:11924–11928

    Article  CAS  Google Scholar 

  28. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88–91

    Article  CAS  PubMed  Google Scholar 

  29. Manolagas SC, Jilka RL, Girasole G, Passeri G, Bellido T (1993) Estrogen, cytokines, and the control of osteoclast formation and bone resorption in vitro and in vivo. Osteoporos Int 3(suppl 1):114–116

    Article  PubMed  Google Scholar 

  30. Passeri G, Girasole G, Jilka RL, Manolagas SC (1993) Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133:822–828

    CAS  PubMed  Google Scholar 

  31. Kanatani M, Sugimoto T, Fukase M, Chihara K (1994) Role of interleukin-6 and prostaglandins in the effect of monocyte-conditioned medium on osteoclast formation. Am J Physiol 267:E868–E876

    CAS  PubMed  Google Scholar 

  32. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD (1990) IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol 144:4226–4230

    CAS  PubMed  Google Scholar 

  33. O'Keefe RJ, Teot LA, Singh D, Puzas JE, Rosier RN, Hicks DG (1997) Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study. Lab Invest 76:457–465

    PubMed  Google Scholar 

  34. Pacifici R (1995) Cytokines and osteoclast activity. Calcif Tissue Int 56(suppl 1):S27–S28

    CAS  PubMed  Google Scholar 

  35. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD (1989) Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113–118

    Article  CAS  PubMed  Google Scholar 

  36. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N (1995) Modulation of osteoclast differentiation by local factors. Bone 17:87S–91S

    Article  CAS  PubMed  Google Scholar 

  37. Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051

    Article  CAS  PubMed  Google Scholar 

  38. Bismar H, Diel I, Ziegler R, Pfeilschifter J (1995) Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 80:3351–3355

    CAS  PubMed  Google Scholar 

  39. Horowitz MC (1993) Cytokines and estrogen in bone: antiosteoporotic effects. Science 260:626–627

    Article  CAS  PubMed  Google Scholar 

  40. McKane WR, Khosla S, Peterson JM, Egan K, Riggs BL (1994) Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women. J Bone Miner Res 9:1313–1318

    Article  CAS  PubMed  Google Scholar 

  41. Zheng SX, Vrindts Y, Lopez M, De Groote D, Zangerle PF, Collette J, Franchimont N, Geehen V, Albert A, Reginster JY (1997) Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas 26:63–71

    Article  CAS  PubMed  Google Scholar 

  42. Kimble RB, Bain S, Pacifici R (1997) The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935–941

    Article  CAS  PubMed  Google Scholar 

  43. Manolagas SC (1995) Role of cytokines in bone resorption. Bone 17:63S–67S

    Article  CAS  PubMed  Google Scholar 

  44. Kawasaki K, Gao YH, Yokose S, Kaji Y, Nakamura T, Suda T, Yoshida K, Taga T, Kishimoto T, Kataoka H, Yuasa T, Norimatsu H, Yamaguchi A (1997) Osteoclasts are present in gp130-deficient mice. Endocrinology 138:4959–4965

    CAS  PubMed  Google Scholar 

  45. Verhaeghe J, Van Herck E, van Bree R, Bouillon R, Dequeker J, Keith JCJ (1998) Recombinant human interleukin-11 does not modify biochemical parameters of bone remodeling and bone mineral density in adult ovariectomized rats. J Interferon Cytokine Res 18:49–53

    Article  CAS  PubMed  Google Scholar 

  46. Miyamoto A, Kunisada T, Hemmi H, Yamane T, Yasuda H, Miyake K, et al (1998) Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. Biochem Biophys Res Commun 242:703–709

    Article  CAS  PubMed  Google Scholar 

  47. Matayoshi A, Brown C, DiPersio JF, Haug J, Abu-Amer Y, Liapis H, Kuestner R, Pacifici R (1996) Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc Natl Acad Sci USA 93:10785–10790

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Pierelli L, Scambia G, d'Onofrio G, Ciarli M, Fattorossi A, Bonanno G, Menichella G, Battaglia A, Benedetti PP, Tommasi M, Mancuso S, Leone G (1997) Generation of multinuclear tartrate-resistant acid phosphatase-positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitors. Br J Haematol 96:64–69

    Article  CAS  PubMed  Google Scholar 

  49. Horwood NJ, Udagawa N, Elliott J, Grail D, Okamura H, Kurimoto M, Dunn AR, Martin T, Gillespie MT (1998) Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest 101:595–603

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787–793

    Article  CAS  PubMed  Google Scholar 

  51. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, et al (1995) Human IL-17: a novel cytokine derived from T cells. J Immunol 155:5483–5486

    CAS  PubMed  Google Scholar 

  52. John V, Hock JM, Short LL, Glasebrook AL, Galvin RJ (1996) A role for CD8+ T lymphocytes in osteoclast differentiation in vitro. Endocrinology 137:2457–2463

    CAS  PubMed  Google Scholar 

  53. van Bezooijen RL, de Grooth R, Farih-Sips H, Papapoulus SE, Lowik CWGM (1997) Interleukin-17: a new bone-acting cytokine. J Bone Miner Res 12(suppl 1):S438

    Google Scholar 

  54. Rothe L, Collin-Osdoby P, Chen Y, Sunyer T, Chaudhary L, Tsay A, Goldring S, Avioli LV, Osdoby P (1998) Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine IL-8. Endocrinology (in press)

    Google Scholar 

  55. Gille J, Swerlick RA, Lawley TJ, Caughman SW (1996) Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood 87:211–217

    CAS  PubMed  Google Scholar 

  56. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP (1995) IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154:799–803

    CAS  PubMed  Google Scholar 

  57. Tanaka Y, Morimoto I, Nakano Y, Okada Y, Hirota S, Nomura S, Nakamura T, Eto S (1995) Osteoblasts are regulated by the cellular adhesion through ICAM- 1 and VCAM-1. J Bone Miner Res 10:1462–1469

    Article  CAS  PubMed  Google Scholar 

  58. Feuerbach D, Feyen JH (1997) Expression of the cell-adhesion molecule VCAM-1 by stromal cells is necessary for osteoclastogenesis. FEBS Lett 402:21–24

    Article  CAS  PubMed  Google Scholar 

  59. Posner LJ, Miligkos T, Gilles JA, Carnes DL, Taddeo DR, Graves DT (1997) Monocyte chemoattractant protein-1 induces monocyte recruitment that is associated with an increase in numbers of osteoblasts. Bone 21:321–327

    Article  CAS  PubMed  Google Scholar 

  60. Volejnikova S, Laskari M, Marks SCJ, Graves DT (1997) Monocyte recruitment and expression of monocyte chemoattractant protein-1 are developmentally regulated in remodeling bone in the mouse. Am J Pathol 150:1711–1721

    CAS  PubMed Central  PubMed  Google Scholar 

  61. Kukita T, Nomiyama H, Ohmoto Y, Kukita A, Shuto T, Hotokebuchi T, et al (1997) Macrophage inflammatory protein-1 alpha (LD78) expressed in human bone marrow: its role in regulation of hematopoiesis and osteoclast recruitment. Lab Invest 76:399–406

    CAS  PubMed  Google Scholar 

  62. Chaudhary LR, Avioli LV (1994) Dexamethasone regulates IL-1 beta and TNF-alpha-induced interleukin-8 production in human bone marrow stromal and osteoblast-like cells. Calcif Tissue Int 55:16–20

    Article  CAS  PubMed  Google Scholar 

  63. Nishiura H, Tanaka J, Takeya M, Tsukano M, Kambara T, Imamura T (1996) IL-8/NAP-1 is the major T-cell chemoattractant in synovial tissues of rheumatoid arthritis. Clin Immunol Immunopathol 80:179–184

    Article  CAS  PubMed  Google Scholar 

  64. Graves DT, Jiang Y (1995) Chemokines, a family of chemotactic cytokines. Crit Rev Oral Biol Med 6:109–118

    Article  CAS  PubMed  Google Scholar 

  65. Kinne RW, Palombo-Kinne E, Emmrich F (1997) T-cells in the pathogenesis of rheumatoid arthritis. Villains or accomplices? Biochim Biophys Acta 1360:109–141

    Article  CAS  PubMed  Google Scholar 

  66. Weyand CM, Goronzy JJ (1997) Pathogenesis of rheumatoid arthritis. Med Clin North Am 81:29–55

    Article  CAS  PubMed  Google Scholar 

  67. Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M (1997) TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis. APMIS 105:257–263

    Article  CAS  PubMed  Google Scholar 

  68. Linsley PS, Ledbetter JA (1993) The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191–212

    Article  CAS  PubMed  Google Scholar 

  69. Webb LM, Walmsley MJ, Feldmann M (1996) Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 costimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 26:2320–2328

    Article  CAS  PubMed  Google Scholar 

  70. Liu MF, Kohsaka H, Sakurai H, Azuma M, Okumura K, Saito I, et al (1996) The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium. Arthritis Rheum 39:110–114

    Article  CAS  PubMed  Google Scholar 

  71. Schmidt D, Goronzy JJ, Weyand CM (1996) CD4+ CD7-CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97:2027–2037

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  72. Barwell R: Diseases of the joints. Hardwicke, London, 1865

    Google Scholar 

  73. Deodhar AA, Woolf AD (1996) Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35:309–322

    Article  CAS  PubMed  Google Scholar 

  74. Dequeker J, Maenaut K, Verwilghen J, Westhovens R (1995) Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol 13(suppl 12):S21–26

    PubMed  Google Scholar 

  75. Star VL, Hochberg MC (1994) Osteoporosis in patients with rheumatic diseases. Rheum Dis Clin North Am 20:561–576

    CAS  PubMed  Google Scholar 

  76. Gough AK, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalized bone loss in patients with early rheumatoid arthritis. Lancet 344:23–27

    Article  CAS  PubMed  Google Scholar 

  77. Wagner S, Fritz P, Einsele H, Sell S, Saal JG (1997) Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteoarthritis by quantitative reverse transcription polymerase chain reaction. Rheumatol Int 16:191–196

    Article  CAS  PubMed  Google Scholar 

  78. Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z (1997) The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum 40:1096–1105

    Article  CAS  PubMed  Google Scholar 

  79. Jones SM, Bhalla AK (1993) Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol 11:557–562

    CAS  PubMed  Google Scholar 

  80. Buchinsky FJ, Ma Y, Mann GN, Rucinski B, Bryer HP, Romero DF, Jee WS, Epstein S (1996) T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia. Endocrinology 137:2278–2285

    CAS  PubMed  Google Scholar 

  81. Schlosberg M, Movsowitz C, Epstein S, Ismail F, Fallon MD, Thomas S (1989) The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179–2184

    Article  CAS  PubMed  Google Scholar 

  82. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S (1988) Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123:2571–2577

    Article  CAS  PubMed  Google Scholar 

  83. Takayanagi H, Oda H, Yamamoto S, Kawaguchi H, Tanaka S, Nishikawa T, Koshihara Y (1997) A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis. Biochem Biophys Res Commun 240:279–286

    Article  CAS  PubMed  Google Scholar 

  84. Tamai M, Sagawa K, Kawabata R, Inoue A, Itoh K (1996) Production of IL-6 by T cells from the femoral head of patients with rapidly destructive coxopathy (RDC). Clin Exp Immunol 103:506-513

    Google Scholar 

  85. Tak PP, Taylor PC, Breedveld FC, Smeets TJ, Daha MR, Kluin PM, Meinders AE, Maini RN (1996) Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 39:1077–1081

    Article  CAS  PubMed  Google Scholar 

  86. Feldmann M, Elliott MJ, Woody JN, Maini RN (1997) Antitumor necrosis factor-alpha therapy of rheumatoid arthritis}. Adv Immunol 64:283–350

    Article  CAS  PubMed  Google Scholar 

  87. Jendro MC, Ganten T, Matteson EL, Weyand CM, Goronzy JJ (1995) Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Arthritis Rheum 38:1242–1251

    Article  CAS  PubMed  Google Scholar 

  88. Quesniaux VF (1993) Immunosuppressants: tools to investigate the physiological role of cytokines. Bioessays 15:731–739

    Article  CAS  PubMed  Google Scholar 

  89. Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, Nourse J, Crabtree GR (1996) The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80:S40–55

    Article  CAS  PubMed  Google Scholar 

  90. Walsh CT, Zydowsky LD, McKeon FD (1992) Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction. J Biol Chem 267:13115–13118

    CAS  PubMed  Google Scholar 

  91. Wechsler AS, Gordon MC, Dendorfer U, LeClair KP (1994) Induction of IL-8 expression in T cells uses the CD28 costimulatory pathway. J Immunol 153:2515–2523

    CAS  PubMed  Google Scholar 

  92. Thiebaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P (1996) Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 26:549–555

    Article  CAS  PubMed  Google Scholar 

  93. Withold W, Wolf HH, Kollbach S, Heyll A, Schneider W, Reinauer H (1996) Monitoring of bone metabolism after bone marrow transplantation by measuring two different markers of bone turnover. Eur J Clin Chem Clin Biochem 34:193-197

    CAS  PubMed  Google Scholar 

  94. Epstein S, Shane E, Bilezikian JP (1995) Organ transplantation and osteoporosis. Curr Opin Rheumatol 7:255–261

    Article  CAS  PubMed  Google Scholar 

  95. Buchinsky FJ, Ma Y, Mann GN, Rucinski B, Bryer HP, Paynton BV, et al (1995) Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat. J Bone Miner Res 10:1556–1565

    Article  CAS  PubMed  Google Scholar 

  96. Sass DA, Liss T, Bowman AR, Rucinski B, Popoff SN, Pan Z, et al (1997) The role of the T lymphocyte in estrogen deficiency osteopenia. J Bone Miner Res 12:479–486

    Article  CAS  PubMed  Google Scholar 

  97. van der Pouw Kraan TC, Boeije LC, Troon JT, Rutschmann SK, Wijdenes J, Aarden LA (1996) Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J Immunol 156:1818–1823

    PubMed  Google Scholar 

  98. Rifas L, Cheng S-L, Avioli LV (1998) IL-13 regulates interleukin-6 production and vascular cell adhesion molecule-1 expression in human osteoblastic cells. Endocrinology (in press)

    Google Scholar 

  99. Rifas L, Avioli LV (1998) T cell cytokine(s) stimulates IL-6 in human osteoblastic cells. J Bone Miner Res (in press)

    Google Scholar 

  100. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS, Frankel WN, Lee SY, Choi Y (1997) TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun Nterminal kinase in T cells. J Biol Chem 272:25190–25194

    Article  CAS  PubMed  Google Scholar 

  101. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y (1997) TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075–2080

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  102. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Gallbert L (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175–179

    Article  CAS  PubMed  Google Scholar 

  103. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597–3602

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  104. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309–319

    Article  CAS  PubMed  Google Scholar 

  105. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165–176

    Article  CAS  PubMed  Google Scholar 

  106. Rifas L, Civitelli R, Avioli LV (1998) Activated T cells stimulate IL-6 production by human osteoblasts via soluble factors and cell contact. J Bone Miner Res 12:S436

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Bone and Mineral Diseases, Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, Missouri, USA

    A. Rifas

Authors
  1. A. Rifas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rifas, A. Bone and Cytokines: Beyond IL-1, IL-6 and TNF-α. Calcif Tissue Int 64, 1–7 (1999). https://doi.org/10.1007/s002239900570

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002239900570

Search

Navigation